Alogliptin Tablet 6.25 mg, 12.5 mg, 25 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 6.25 mg, 12.5 mg, 25 mg

Reference Brands: Nesina (USA/EU), Kazano (USA), Vipidia (EU)

Category: Diabetes

Alogliptin tablets (6.25 mg, 12.5 mg, 25 mg) are a DPP-4 inhibitor for type 2 diabetes, taken once daily with or without metformin or pioglitazone. It rarely causes low blood sugar and does not cause weight gain. Reference brands are Nesina and Vipidia, with combination products Kazano and Oseni. Patent status differs by country, so we confirm what can lawfully be supplied to your destination before quoting.

Product Description:

Alogliptin tablets are oral antidiabetic medications used for the management of type 2 diabetes mellitus, particularly in patients who are unable to achieve adequate glycemic control through diet and exercise alone. The active ingredient, alogliptin benzoate, belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the levels of incretin hormones such as GLP-1 and GIP, which play a key role in regulating blood glucose levels. These hormones stimulate insulin release from the pancreas in response to meals and reduce the amount of glucose produced by the liver. As a result, alogliptin helps lower both fasting and postprandial blood sugar levels without causing significant hypoglycemia when used alone. The medication is generally well tolerated and is often prescribed either as monotherapy or in combination with other antidiabetic agents. Its once-daily dosing improves patient compliance, making it a convenient and effective option for long-term diabetes management.